Concepedia

Paul Gonzales

PG

Statistics

Publications

8

Citations

416

H-Index

8

Active since

2004

Affiliations

Translational Genomics Research Institute(Current)

Brooke Army Medical Center

Paul Gonzales is an author at Translational Genomics Research Institute specializing in pharmacology, oncology, and molecular oncology.

ORCID

Publications per year

2004–2024

8

Publications

8

Antitumor Activity of a Kinesin Inhibitor

Roman Sakowicz, Jeffrey T. Finer, Christophe Béraud et al. · Cancer Research · 2004 · 241 citations

, , +17

Synthesis of Improved Lysomotropic Autophagy Inhibitors

Tong Wang, Megan L. Goodall, Paul Gonzales et al. · Journal of Medicinal Chemistry · 2015 · 38 citations

, , +17

Plinabulin, an inhibitor of tubulin polymerization, targets KRAS signaling through disruption of endosomal recycling

Patrick J. Cimino, Lan Huang, Lihua Du et al. · Biomedical Reports · 2019 · 34 citations · Full text

, , +14

Targeting polo‐like kinase 1, a regulator of p53, in the treatment of adrenocortical carcinoma

Kimberly J. Bussey, Aditi Bapat, Claire Linnehan et al. · Clinical and Translational Medicine · 2016 · 33 citations · Full text

, , +17

Identification of novel HDAC inhibitors through cell based screening and their evaluation as potential anticancer agents

Tong Wang, Mario Sepulveda, Paul Gonzales et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 23 citations · Full text

, , +9

1–5 of 8